Bucol, Sarah Jane C.

HRN: 16-06-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 750MG (VIAL)
11/19/2025
11/26/2025
IV
750mg
Q 8 Hours
Presumptive PTB
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: